This is to inform you that, the Board of Directors of the Company at its meeting held on Thursday, 13 th of November, 2025 at the Registered Office of the Company inter alia considered & ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, along with a limited review report from auditors Shah & Jhalawadia (clean opinion, no qualifications). Consolidated revenue from operations surged to ₹636.54 lakhs in Q2 FY26 versus ₹199.97 lakhs in Q2 FY25, while H1 FY26 revenue rose to ₹636.54 lakhs from ₹474.27 lakhs. Consolidated net profit for Q2 jumped to ₹94.90 lakhs from ₹46.71 lakhs, though H1 FY26 profit declined to ₹86.33 lakhs versus ₹167.43 lakhs last year. Standalone Q2 PAT rose to ₹93.71 lakhs from ₹50.23 lakhs, with EPS at ₹0.26. The company also filed a deviation report for its April 2023 Rights Issue: of ₹48.17 crore raised for 'investments in main object related business,' ₹42.73 crore was instead used for working capital and corporate purposes, leaving ₹5.44 crore unutilized in an IDFC First Bank account.
Strong quarterly revenue and profit growth signals improving operational momentum, but the sharp H1 FY26 profit decline versus last year and the ongoing deviation in use of rights issue proceeds (funds diverted from stated business investment purpose to working capital) may raise investor concerns about capital allocation discipline.